GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 6 analysts with an average price target of $31.44. This is a potential upside of $-5.88 (-15.76%) from yesterday's end of day stock price of $37.32.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 127 price targets and 86 ratings on display. The stock rating distribution of GSK is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.49% with an average time for these price targets to be met of 314.28 days.

Highest price target for GSK is $41, Lowest price target is $41, average price target is $43.33.

Most recent stock forecast was given by KERRY HOLFORD from BERENBERG on 02-Dec-2024. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$41

$3.85 (10.36%)

8 months 3 days ago
(02-Dec-2024)

1/1 (100%)

$6.69 (19.50%)

179

Hold

$53

8 months 24 days ago
(12-Nov-2024)

2/4 (50%)

$15.58 (41.64%)

379

Buy

1 years 4 days ago
(01-Aug-2024)

1/13 (7.69%)

$-10.5 (-32.65%)

64

Buy

$45

$7.85 (21.13%)

$47

1 years 20 days ago
(16-Jul-2024)

1/3 (33.33%)

$6.9 (18.11%)

2259

Buy

$19.52

1 years 5 months 23 days ago
(13-Feb-2024)

0/3 (0%)

$-13.88 (-41.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 314.28 days on average for the stock forecasts to be realized with a an average price target met ratio 25.49

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

JUSTIN SMITH

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Justin Smith works at SOCGEN and has 3 price targets and 2 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

John Eade with highest potential upside - $7.85

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Eric Le Berrigaud with lowest potential downside - -$22.45

GlaxoSmithKline PLC ADR in the News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have engaged in securities fraud...

India's GlaxoSmithKline Pharma posts first revenue drop in over two years

(Reuters) -Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, leading to its shares declining the most in nearly four months. The Indian unit of British drugmaker GSK Plc reported a 2% decline in its revenue from operations to 8.05 billion rupees ($92 million)for the first quarter...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?